Nanhua Bio (China) Top Management

Nanhua Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.0455) % which means that it has lost $0.0455 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.313) %, meaning that it generated substantial loss on money invested by shareholders. Nanhua Bio's management efficiency ratios could be used to measure how well Nanhua Bio manages its routine affairs as well as how well it operates its assets and liabilities. At present, Nanhua Bio's Other Assets are projected to decrease significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 6 M, whereas Total Assets are forecasted to decline to about 359.5 M. As of March 25, 2025, Common Stock Shares Outstanding is expected to decline to about 345.6 M. The current year's Net Loss is expected to grow to about (10.9 M)

Nanhua Bio Workforce Comparison

The company has Profit Margin (PM) of (0.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.

Nanhua Bio Medicine Benchmark Summation

Nanhua Bio Notable Stakeholders

The success or failure of an entity such as Nanhua Bio Medicine often depends on how effective the management is. Nanhua Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nanhua management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nanhua management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Nanhua Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nanhua Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nanhua Bio's management manipulating its earnings.

When running Nanhua Bio's price analysis, check to measure Nanhua Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanhua Bio is operating at the current time. Most of Nanhua Bio's value examination focuses on studying past and present price action to predict the probability of Nanhua Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanhua Bio's price. Additionally, you may evaluate how the addition of Nanhua Bio to your portfolios can decrease your overall portfolio volatility.